☰

Shaozhen Xie, Ph.D. - Publications

Affiliations: 
2007 University of Rochester, Rochester, NY 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

19/38 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Bhat SA, Sarwar Z, Gillani Q, Un Nisa M, Reshi I, Nabi N, Xie S, Fazili KM, Roberts TM, Andrabi S. Polyoma Small T antigen Induces Apoptosis In Mammalian Cells Through UNC5B Pathway In A PP2A Dependent Manner. Journal of Virology. PMID 32404521 DOI: 10.1128/Jvi.02187-19  0.342
2016 Ni J, Xie S, Ramkissoon SH, Luu V, Sun Y, Bandopadhayay P, Beroukhim R, Roberts TM, Stiles CD, Segal RA, Ligon KL, Hahn WC, Zhao JJ. Tyrosine receptor kinase B is a drug target in astrocytomas. Neuro-Oncology. PMID 27402815 DOI: 10.1093/Neuonc/Now139  0.32
2016 Fan W, Xie S, Zhao X, Li N, Chang C, Li L, Yu G, Chi X, Pan Y, Niu J, Zhong J, Sun B. IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18. The Journal of General Virology. PMID 27302182 DOI: 10.1099/Jgv.0.000522  0.357
2015 Luo W, Chen Y, Wang T, Hong C, Chang LP, Chang CC, Yang YC, Xie SQ, Wang CJ. Design, synthesis and evaluation of novel 7-aminoalkyl-substituted flavonoid derivatives with improved cholinesterase inhibitory activities. Bioorganic & Medicinal Chemistry. PMID 26752094 DOI: 10.1016/j.bmc.2015.12.031  0.332
2011 Xie S, Ni J, Lee YF, Liu S, Li G, Shyr CR, Chang C. Increased acetylation in the DNA-binding domain of TR4 nuclear receptor by the coregulator ARA55 leads to suppression of TR4 transactivation. The Journal of Biological Chemistry. 286: 21129-36. PMID 21515881 DOI: 10.1074/Jbc.M110.208181  0.713
2009 Xie S, Lee YF, Kim E, Chen LM, Ni J, Fang LY, Liu S, Lin SJ, Abe J, Berk B, Ho FM, Chang C. TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation. Proceedings of the National Academy of Sciences of the United States of America. 106: 13353-8. PMID 19666541 DOI: 10.1073/Pnas.0905724106  0.703
2008 Li G, Lee YF, Liu S, Cai Y, Xie S, Liu NC, Bao BY, Chen Z, Chang C. Oxidative stress stimulates testicular orphan receptor 4 through forkhead transcription factor forkhead box O3a. Endocrinology. 149: 3490-9. PMID 18388194 DOI: 10.1210/En.2008-0121  0.729
2008 Chen LM, Wang RS, Lee YF, Liu NC, Chang YJ, Wu CC, Xie S, Hung YC, Chang C. Subfertility with defective folliculogenesis in female mice lacking testicular orphan nuclear receptor 4. Molecular Endocrinology (Baltimore, Md.). 22: 858-67. PMID 18174360 DOI: 10.1210/Me.2007-0181  0.732
2007 Shi W, Chang C, Nie S, Xie S, Wan M, Cao X. Endofin acts as a Smad anchor for receptor activation in BMP signaling. Journal of Cell Science. 120: 1216-24. PMID 17356069 DOI: 10.1242/Jcs.03400  0.515
2007 Zhang Y, Chen YT, Xie S, Wang L, Lee YF, Chang SS, Chang C. Loss of testicular orphan receptor 4 impairs normal myelination in mouse forebrain. Molecular Endocrinology (Baltimore, Md.). 21: 908-20. PMID 17227886 DOI: 10.1210/Me.2006-0219  0.69
2006 Ni J, Wen X, Yao JL, Yin Y, Zhang M, Xie S, Chen M, Simons B, Disant'agnese A, Messing EM, Yeh S. 823: Tocopherol Associated Protein Suppresses Prostate Cancer Cell Growth by Inhibition of the PI3 Kinase Pathway Journal of Urology. 175: 265-266. DOI: 10.1016/S0022-5347(18)33059-3  0.452
2005 Ni J, Wen X, Yao J, Chang HC, Yin Y, Zhang M, Xie S, Chen M, Simons B, Chang P, di Sant'Agnese A, Messing EM, Yeh S. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Research. 65: 9807-16. PMID 16267002 DOI: 10.1158/0008-5472.Can-05-1334  0.48
2005 Yang L, Xie S, Jamaluddin MS, Altuwaijri S, Ni J, Kim E, Chen YT, Hu YC, Wang L, Chuang KH, Wu CT, Chang C. Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells. The Journal of Biological Chemistry. 280: 33558-65. PMID 16061480 DOI: 10.1074/Jbc.M504461200  0.707
2004 Wang L, Lin HK, Hu YC, Xie S, Yang L, Chang C. Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells. The Journal of Biological Chemistry. 279: 32444-52. PMID 15178691 DOI: 10.1074/Jbc.M313963200  0.741
2004 Xie S, Lin HK, Ni J, Yang L, Wang L, di Sant'Agnese PA, Chang C. Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells. The Prostate. 60: 61-7. PMID 15129430 DOI: 10.1002/Pros.20048  0.683
2004 Yang L, Yeh SD, Xie S, Altuwaijri S, Ni J, Hu YC, Chen YT, Bao BY, Su CH, Chang C. Androgen suppresses PML protein expression in prostate cancer CWR22R cells. Biochemical and Biophysical Research Communications. 314: 69-75. PMID 14715247 DOI: 10.1016/J.Bbrc.2003.12.060  0.767
2003 Kim E, Xie S, Yeh SD, Lee YF, Collins LL, Hu YC, Shyr CR, Mu XM, Liu NC, Chen YT, Wang PH, Chang C. Disruption of TR4 orphan nuclear receptor reduces the expression of liver apolipoprotein E/C-I/C-II gene cluster. The Journal of Biological Chemistry. 278: 46919-26. PMID 12954636 DOI: 10.1074/Jbc.M304088200  0.684
2003 Yang L, Wang L, Lin HK, Kan PY, Xie S, Tsai MY, Wang PH, Chen YT, Chang C. Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells. Biochemical and Biophysical Research Communications. 305: 462-9. PMID 12763015 DOI: 10.1016/S0006-291X(03)00792-7  0.689
2003 Yang L, Lin HK, Altuwaijri S, Xie S, Wang L, Chang C. APPL suppresses androgen receptor transactivation via potentiating Akt activity. The Journal of Biological Chemistry. 278: 16820-7. PMID 12621049 DOI: 10.1074/Jbc.M213163200  0.764
Low-probability matches (unlikely to be authored by this person)
2012 Gao T, Gao Y, Chang C, Chen Y, Liu M, Xie S, He K, Ma X, Zhang Y, Liu Z. Atomic-scale morphology and electronic structure of manganese atomic layers underneath epitaxial graphene on SiC(0001). Acs Nano. 6: 6562-8. PMID 22861188 DOI: 10.1021/Nn302303N  0.287
2023 He X, Wei Y, Wu J, Wang Q, Bergholz JS, Gu H, Zou J, Lin S, Wang W, Xie S, Jiang T, Lee J, Asara JM, Zhang K, Cantley LC, et al. Lysine vitcylation is a novel vitamin C-derived protein modification that enhances STAT1-mediated immune response. Biorxiv : the Preprint Server For Biology. PMID 37425798 DOI: 10.1101/2023.06.27.546774  0.252
2016 Cizmecioglu O, Ni J, Xie S, Zhao JJ, Roberts TM. Rac1-mediated membrane raft localization of PI3K/p110β is required for its activation by GPCRs or PTEN loss. Elife. 5. PMID 27700986 DOI: 10.7554/Elife.17635  0.251
2015 Wang Y, Zhang T, Kwiatkowski N, Abraham BJ, Lee TI, Xie S, Yuzugullu H, Von T, Li H, Lin Z, Stover DG, Lim E, Wang ZC, Iglehart JD, Young RA, et al. CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer. Cell. 163: 174-186. PMID 26406377 DOI: 10.1016/J.Cell.2015.08.063  0.25
2012 Ni J, Liu Q, Xie S, Carlson C, Von T, Vogel K, Riddle S, Benes C, Eck M, Roberts T, Gray N, Zhao J. Functional characterization of an isoform-selective inhibitor of PI3K-p110β as a potential anticancer agent. Cancer Discovery. 2: 425-33. PMID 22588880 DOI: 10.1158/2159-8290.Cd-12-0003  0.233
2017 Goel S, DeCristo MJ, Watt AC, BrinJones H, Sceneay J, Li BB, Khan N, Ubellacker JM, Xie S, Metzger-Filho O, Hoog J, Ellis MJ, Ma CX, Ramm S, Krop IE, et al. CDK4/6 inhibition triggers anti-tumour immunity. Nature. PMID 28813415 DOI: 10.1038/Nature23465  0.226
2020 Xie S, Ni J, McFaline-Figueroa JR, Wang Y, Bronson RT, Ligon KL, Wen PY, Roberts TM, Zhao JJ. Divergent Roles of PI3K Isoforms in PTEN-Deficient Glioblastomas. Cell Reports. 32: 108196. PMID 32997991 DOI: 10.1016/j.celrep.2020.108196  0.22
2024 Gu H, Chen C, Hou ZS, He XD, Xie S, Ni J, Qian C, Cheng X, Jiang T, Yang C, Roberts TM, Zheng J, Varner JA, Armstrong SA, Zhao JJ. PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway. Blood. PMID 38271660 DOI: 10.1182/blood.2023022202  0.203
2023 Bergholz JS, Wang Q, Wang Q, Ramseier M, Prakadan S, Wang W, Fang R, Kabraji S, Zhou Q, Gray GK, Abell-Hart K, Xie S, Guo X, Gu H, Von T, et al. PI3Kβ controls immune evasion in PTEN-deficient breast tumours. Nature. PMID 37076617 DOI: 10.1038/s41586-023-05940-w  0.202
2009 Ni J, Mai T, Pang ST, Haque I, Huang K, DiMaggio MA, Xie S, James NS, Kasi D, Chemler SR, Yeh S. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 898-906. PMID 19188160 DOI: 10.1158/1078-0432.Ccr-08-1087  0.189
2021 Xie S, Ni J, Guo H, Luu V, Wang Y, Zhao JJ, Roberts TM. The role of the PIK3CA gene in the development and aging of the brain. Scientific Reports. 11: 291. PMID 33431926 DOI: 10.1038/s41598-020-79416-6  0.178
2023 Ding L, Wang Q, Martincuks A, Kearns MJ, Jiang T, Lin Z, Cheng X, Qian C, Xie S, Kim HJ, Launonen IM, Färkkilä A, Roberts TM, Freeman GJ, Liu JF, et al. STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer. Journal For Immunotherapy of Cancer. 11. PMID 36609487 DOI: 10.1136/jitc-2022-005627  0.173
2016 Ni J, Ramkissoon SH, Xie S, Goel S, Stover DG, Guo H, Luu V, Marco E, Ramkissoon LA, Kang YJ, Hayashi M, Nguyen QD, Ligon AH, Du R, Claus EB, et al. Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases. Nature Medicine. PMID 27270588 DOI: 10.1038/Nm.4120  0.164
1987 Xie S, Threlfall W, Sanbuissho A. Endometrial cell and luteal cell coculture with hamster embryos Theriogenology. 27: 296. DOI: 10.1016/0093-691X(87)90173-7  0.159
2018 Ding L, Kim HJ, Wang Q, Kearns M, Jiang T, Ohlson CE, Li BB, Xie S, Liu JF, Stover EH, Howitt BE, Bronson RT, Lazo S, Roberts TM, Freeman GJ, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Reports. 25: 2972-2980.e5. PMID 30540933 DOI: 10.1016/J.Celrep.2018.11.054  0.146
2022 Wang Q, Bergholz JS, Ding L, Lin Z, Kabraji SK, Hughes ME, He X, Xie S, Jiang T, Wang W, Zoeller JJ, Kim HJ, Roberts TM, Konstantinopoulos PA, Matulonis UA, et al. STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer. Nature Communications. 13: 3022. PMID 35641483 DOI: 10.1038/s41467-022-30568-1  0.128
2022 Ni J, Kabraji S, Xie S, Wang Y, Pan P, He X, Liu Z, Leone JP, Long HW, Brown MA, Winer EP, Dillon DAR, Lin NU, Zhao JJ. p16-deficiency predicts response to combined HER2 and CDK4/6 inhibition in HER2+ breast cancer brain metastases. Nature Communications. 13: 1473. PMID 35304445 DOI: 10.1038/s41467-022-29081-2  0.104
2018 Kabraji S, Ni J, Lin N, Xie S, Winer EP, Zhao JJ. Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the brain? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29437794 DOI: 10.1158/1078-0432.CCR-17-3351  0.075
2019 Liu Z, Wang Y, Kabraji S, Xie S, Pan P, Liu Z, Ni J, Zhao JJ. Improving orthotopic mouse models of patient-derived breast cancer brain metastases by a modified intracarotid injection method. Scientific Reports. 9: 622. PMID 30679540 DOI: 10.1038/s41598-018-36874-3  0.07
Hide low-probability matches.